Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia.

Autor:	McFadden R; From the Prevention Point Philadelphia, Philadelphia, PA (RMF, SW-K, KPS, RH, KMN); Center for Addiction Medicine and Policy (CAMP), University of Pennsylvania, Philadelphia, PA (RMF, APT); Stephen Klein Wellness Center, Project HOME, Philadelphia, PA (SW-K); Leonard A. Lauder Community Care Nurse Practitioner Program, University of Pennsylvania School of Nursing, Philadelphia, PA (RH); Division of Substance Use Prevention and Harm Reduction, Philadelphia Department of Public Health, Philadelphia, PA (RN); and Division of General Internal Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (APT)., Wallace-Keeshen S, Petrillo Straub K, Hosey RA, Neuschatz R, McNulty K, Thakrar AP
Jazyk:	angličtina
Zdroj:	Journal of addiction medicine [J Addict Med] 2024 Jan-Feb 01; Vol. 18 (1), pp. 9-12. Date of Electronic Publication: 2023 Nov 29.
DOI:	10.1097/ADM.0000000000001245
Abstrakt:	Abstract: The veterinary sedative xylazine is spreading in unregulated opioid supplies across North America. Among people who use drugs with repeated exposure to xylazine, a distinct wound type has emerged. Here, we describe these wounds and share our experience treating them in a nurse-led, low-barrier wound care clinic in Philadelphia, PA. We propose a reimagining of wound treatment across settings to better serve people who use drugs, and we advocate for stronger protections against the harms of an increasingly adulterated drug supply. Our perspective from the epicenter of the xylazine crisis can inform the response of communities across the country who are starting to face harms associated with xylazine. Competing Interests: The authors report no conflicts of interest. (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Addiction Medicine.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu